Clark Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Clark Wealth Partners's LLY Position: Q2 2026 in Review
Clark Wealth Partners increased its Eli Lilly (LLY) stake by 2.9% in Q2 2026, buying an estimated $10.2K and bringing the position to 353 shares worth $423K. The position accounts for 0.24% of the portfolio, ranked #47.
Clark Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Clark Wealth Partners held 353 shares of Eli Lilly worth $423K as of Q2 2026.
- Clark Wealth Partners bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
- Eli Lilly made up 0.24% of Clark Wealth Partners's portfolio in Q2 2026, its #47 holding.
- Clark Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.